PRNP and prion disease: The PrP dependence of all prion disease, regardless of etiology or even species, has long nominated the therapeutic hypothesis of PrP reduction [4], and antisense oligonucleotides (ASOs) against the prion protein RNA now provide pharmacological proof of concept for this treatment strategy [5].